• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用携带凋亡蛋白的单纯疱疹病毒扩增子载体,在雪旺细胞启动子的作用下,对实验性雪旺细胞瘤进行成像和治疗。

Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter.

机构信息

Neuroscience Center, Massachusetts General Hospital, Boston, MA 02129, USA.

出版信息

Cancer Gene Ther. 2010 Apr;17(4):266-74. doi: 10.1038/cgt.2009.71. Epub 2009 Oct 16.

DOI:10.1038/cgt.2009.71
PMID:19834516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2857743/
Abstract

Schwannomas are benign tumors forming along peripheral nerves that can cause deafness, pain and paralysis. Current treatment involves surgical resection, which can damage associated nerves. To achieve tumor regression without damage to nerve fibers, we generated an HSV amplicon vector in which the apoptosis-inducing enzyme, caspase-1 (ICE), was placed under the Schwann cell-specific P0 promoter. Infection of schwannoma, neuroblastoma and fibroblastic cells in culture with ICE under the P0 promoter showed selective toxicity to schwannoma cells, while ICE under a constitutive promoter was toxic to all cell types. After direct intratumoral injection of the P0-ICE amplicon vector, we achieved marked regression of schwannoma tumors in an experimental xenograft mouse model. Injection of this amplicon vector into the sciatic nerve produced no apparent injury to the associated dorsal root ganglia neurons or myelinated nerve fibers. The P0-ICE amplicon vector provides a potential means of 'knifeless resection' of schwannoma tumors by injection of the vector into the tumor with low risk of damage to associated nerve fibers.

摘要

施万细胞瘤是沿着外周神经形成的良性肿瘤,可导致耳聋、疼痛和瘫痪。目前的治疗方法包括手术切除,这可能会损伤相关的神经。为了在不损伤神经纤维的情况下实现肿瘤消退,我们生成了一种 HSV 扩增子载体,其中凋亡诱导酶 caspase-1(ICE)置于 Schwann 细胞特异性 P0 启动子下。在 P0 启动子下,用 ICE 感染培养的施万细胞瘤、神经母细胞瘤和成纤维细胞显示出对施万细胞瘤的选择性毒性,而组成型启动子下的 ICE 对所有细胞类型都有毒性。在实验性异种移植小鼠模型中,直接瘤内注射 P0-ICE 扩增子载体后,我们实现了施万细胞瘤的显著消退。将这种扩增子载体注入坐骨神经,对相关的背根神经节神经元或有髓神经纤维没有明显的损伤。P0-ICE 扩增子载体通过将载体注入肿瘤中,为施万细胞瘤的“无刀切除”提供了一种潜在的手段,同时降低了损伤相关神经纤维的风险。

相似文献

1
Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter.应用携带凋亡蛋白的单纯疱疹病毒扩增子载体,在雪旺细胞启动子的作用下,对实验性雪旺细胞瘤进行成像和治疗。
Cancer Gene Ther. 2010 Apr;17(4):266-74. doi: 10.1038/cgt.2009.71. Epub 2009 Oct 16.
2
Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1.腺相关病毒介导的胱天蛋白酶-1 递送诱导神经鞘瘤消退
Hum Gene Ther. 2013 Feb;24(2):152-62. doi: 10.1089/hum.2012.094. Epub 2013 Jan 30.
3
Treatment of implantable NF2 schwannoma tumor models with oncolytic herpes simplex virus G47Delta.用溶瘤性单纯疱疹病毒G47Delta治疗可植入性NF2神经鞘瘤肿瘤模型。
Cancer Gene Ther. 2007 May;14(5):460-7. doi: 10.1038/sj.cgt.7701037. Epub 2007 Feb 16.
4
Schwannoma Gene Therapy via Adeno-Associated Viral Vector Delivery of Apoptosis-Associated Speck-like Protein Containing CARD (ASC): Preclinical Efficacy and Safety.施万细胞瘤的基因治疗:通过腺相关病毒载体传递含 CARD 的凋亡相关斑点样蛋白(ASC):临床前疗效和安全性。
Int J Mol Sci. 2022 Jan 13;23(2):819. doi: 10.3390/ijms23020819.
5
Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2.在2型神经纤维瘤病小鼠模型中,用溶瘤重组单纯疱疹病毒治疗神经鞘瘤。
Hum Gene Ther. 2006 Jan;17(1):20-30. doi: 10.1089/hum.2006.17.20.
6
Schwannoma gene therapy by adeno-associated virus delivery of the pore-forming protein Gasdermin-D.腺相关病毒递送孔形成蛋白 Gasdermin-D 进行施旺细胞瘤基因治疗。
Cancer Gene Ther. 2019 Sep;26(9-10):259-267. doi: 10.1038/s41417-018-0077-3. Epub 2019 Jan 9.
7
Developing myelin specific promoters for schwannoma gene therapy.开发雪旺细胞瘤基因治疗的髓鞘特异性启动子。
J Neurosci Methods. 2019 Jul 15;323:77-81. doi: 10.1016/j.jneumeth.2019.05.007. Epub 2019 May 22.
8
Bioluminescence imaging after HSV amplicon vector delivery into brain.将单纯疱疹病毒扩增子载体导入大脑后的生物发光成像。
J Gene Med. 2006 Jul;8(7):804-13. doi: 10.1002/jgm.909.
9
Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo.利用凋亡相关斑点样蛋白(一种新描述的神经鞘瘤肿瘤抑制因子)进行基因治疗,可抑制体内神经鞘瘤的生长。
Neuro Oncol. 2019 Jul 11;21(7):854-866. doi: 10.1093/neuonc/noz065.
10
Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.由无辅助病毒的单纯疱疹病毒/腺相关病毒杂交载体介导的基因向肝细胞的转移。
Mol Med. 1997 Dec;3(12):813-25.

引用本文的文献

1
Pathologic and Therapeutic Schwann Cells.病理性与治疗性施万细胞
Cells. 2025 Aug 28;14(17):1336. doi: 10.3390/cells14171336.
2
Gene therapy and genome-editing for schwannoma in NF2-related schwannomatosis: current understanding and future directions.神经纤维瘤病2型相关神经鞘瘤病中神经鞘瘤的基因治疗和基因组编辑:当前认识与未来方向
J Neurooncol. 2025 Mar 7. doi: 10.1007/s11060-025-04995-1.
3
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.2型神经纤维瘤病相关神经鞘瘤病的基因治疗:最新进展、挑战与未来方向
Oncol Ther. 2024 Jun;12(2):257-276. doi: 10.1007/s40487-024-00279-2. Epub 2024 May 17.
4
Culture of attenuated Typhimurium VNP20009 in animal-product-free media does not alter schwannoma growth control.在无动物产品培养基中培养减毒鼠伤寒沙门氏菌 VNP20009 不会改变施万细胞瘤的生长控制。
Hum Vaccin Immunother. 2023 Aug;19(2):2262639. doi: 10.1080/21645515.2023.2262639. Epub 2023 Oct 3.
5
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.2型神经纤维瘤病雪旺细胞瘤小鼠模型中的基因替代疗法
Mol Ther Methods Clin Dev. 2022 Jun 22;26:169-180. doi: 10.1016/j.omtm.2022.06.012. eCollection 2022 Sep 8.
6
Schwannoma Gene Therapy via Adeno-Associated Viral Vector Delivery of Apoptosis-Associated Speck-like Protein Containing CARD (ASC): Preclinical Efficacy and Safety.施万细胞瘤的基因治疗:通过腺相关病毒载体传递含 CARD 的凋亡相关斑点样蛋白(ASC):临床前疗效和安全性。
Int J Mol Sci. 2022 Jan 13;23(2):819. doi: 10.3390/ijms23020819.
7
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates.对表达人白细胞介素-12的减毒1型单纯疱疹病毒M032经脑内注射给夜猴属非人灵长类动物后的安全性和生物分布进行评估。
Hum Gene Ther Clin Dev. 2014 Mar;25(1):16-27. doi: 10.1089/humc.2013.201.
8
Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1.腺相关病毒介导的胱天蛋白酶-1 递送诱导神经鞘瘤消退
Hum Gene Ther. 2013 Feb;24(2):152-62. doi: 10.1089/hum.2012.094. Epub 2013 Jan 30.
9
Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth.携带自杀 mRNA/蛋白的基因工程微小囊泡抑制雪旺细胞瘤生长。
Mol Ther. 2013 Jan;21(1):101-8. doi: 10.1038/mt.2012.161. Epub 2012 Aug 21.
10
Cancer imaging: Gene transcription-based imaging and therapeutic systems.癌症成像:基于基因转录的成像和治疗系统。
Int J Biochem Cell Biol. 2012 May;44(5):684-9. doi: 10.1016/j.biocel.2012.02.001. Epub 2012 Feb 10.

本文引用的文献

1
A novel imaging-compatible sciatic nerve schwannoma model.一种新型的可成像兼容的坐骨神经鞘瘤模型。
J Neurosci Methods. 2011 Jan 30;195(1):75-7. doi: 10.1016/j.jneumeth.2010.10.021. Epub 2010 Nov 24.
2
Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.NF2相关前庭神经鞘瘤对厄洛替尼治疗的听力学和影像学反应
Nat Clin Pract Oncol. 2008 Aug;5(8):487-91. doi: 10.1038/ncponc1157. Epub 2008 Jun 17.
3
Neurofibromatosis.神经纤维瘤病
Annu Rev Pathol. 2007;2:191-216. doi: 10.1146/annurev.pathol.2.010506.091940.
4
Engineering an improved cell cycle-regulatable herpes simplex virus type 1 amplicon vector with enhanced transgene expression in proliferating cells yet attenuated activities in resting cells.
Hum Gene Ther. 2007 Mar;18(3):222-31. doi: 10.1089/hum.2006.140.
5
Treatment of implantable NF2 schwannoma tumor models with oncolytic herpes simplex virus G47Delta.用溶瘤性单纯疱疹病毒G47Delta治疗可植入性NF2神经鞘瘤肿瘤模型。
Cancer Gene Ther. 2007 May;14(5):460-7. doi: 10.1038/sj.cgt.7701037. Epub 2007 Feb 16.
6
Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model.溶瘤单纯疱疹病毒和厄洛替尼在一种新型恶性外周神经鞘瘤异种移植模型中抑制肿瘤生长和血管生成。
Mol Ther. 2007 Feb;15(2):279-86. doi: 10.1038/sj.mt.6300038.
7
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.一项关于OncoVEXGM-CSF的I期研究,OncoVEXGM-CSF是一种表达粒细胞巨噬细胞集落刺激因子的第二代溶瘤单纯疱疹病毒。
Clin Cancer Res. 2006 Nov 15;12(22):6737-47. doi: 10.1158/1078-0432.CCR-06-0759.
8
Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver.一项关于基因工程单纯疱疹病毒NV1020用于肝转移结直肠癌患者的I期开放标签剂量递增研究。
Hum Gene Ther. 2006 Dec;17(12):1214-24. doi: 10.1089/hum.2006.17.1214.
9
HSV amplicon vectors for cancer therapy.用于癌症治疗的单纯疱疹病毒扩增子载体。
Curr Gene Ther. 2006 Jun;6(3):361-70. doi: 10.2174/156652306777592063.
10
The transcription factor ATF-3 promotes neurite outgrowth.转录因子ATF-3促进神经突生长。
Mol Cell Neurosci. 2006 May-Jun;32(1-2):143-54. doi: 10.1016/j.mcn.2006.03.005. Epub 2006 May 19.